Metraipolis › archive › dc_f77e5d027ff1
China's regulatory regime for medical biotechnology: evolution, challenges, and future perspectives — Europe PMC PMID:42344528
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42344528
- DOI
- 10.3389/fmedt.2026.1805452
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-31T15:31:33.995Z
- SHA-256 of the archived text
ad1ecb11a782da97e0d589eabb0ac8c78f132122c6b09c2764da33bc14286564- Stable URL of this page
https://metraipolis.com/documento/dc_f77e5d027ff1
How to cite
China's regulatory regime for medical biotechnology: evolution, challenges, and future perspectives — Europe PMC PMID:42344528 — Europe PMC (en), https://europepmc.org/article/MED/42344528 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f77e5d027ff1 (Metraipolis archive dc_f77e5d027ff1, sha256 ad1ecb11a782da97e0d589eabb0ac8c78f132122c6b09c2764da33bc14286564)
BibTeX
@misc{dcf77e5d027ff1,
title = {China's regulatory regime for medical biotechnology: evolution, challenges, and future perspectives — Europe PMC PMID:42344528},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42344528},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f77e5d027ff1; sha256 ad1ecb11a782da97e0d589eabb0ac8c78f132122c6b09c2764da33bc14286564},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42344528. Agents can read the archived copy with the MCP tool read_document.